Covalon Technologies Ltd Corporate Call to Discuss CovaGuard Antimicrobial Technology Transcript
Good morning, ladies and gentlemen. And thank you for joining Covalon's conference call to [discuss] its new CovaGuard technology. As a reminder, today's conference is recorded. At this time, I would like to turn the conference over to Mr. Brian Pedlar, President, and Chief Executive Officer; and Mr. Danny Brannagan, Chief Financial Officer.
Please go ahead, Mr. Pedlar and Mr. Brannagan
Thank you Megan. My name is Danny Brannagan. And as Covalon's Chief Financial Officer, I would like to thank everyone for taking the time this morning to attend our conference call. We will be discussing the recent press release related to Covalon's CovaGuard technology. There will be an opportunity for you to ask questions at the end of our call.
Before we begin the discussion, I would like to remind participants that this call is covered by Covalon's Safe Harbor statements. Certain statements included on this conference call may be considered forward looking. Such statements involve known and unknown risks,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |